Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
Prospective, open label study to assess the pharmacokinetics, safety & efficacy of
anidulafungin when used to treat children (aged 1 month - <18 years) with invasive
candidiasis, including candidemia (ICC).